FDA Inspection 1272781 — AbbVie Deutschland GmbH & Co. KG
The FDA completed an inspection of AbbVie Deutschland GmbH & Co. KG on May 16, 2025 in Ludwigshafen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ludwigshafen (Germany)
Additional Details
Bioanalytical BA/BE